What is the address of DR. BOER MIRRA, ENDOCRINOLOOG?

The registered office of DR. BOER MIRRA, ENDOCRINOLOOG is located at Meirebeekstraat 52, 9800 Deinze.

Is DR. BOER MIRRA, ENDOCRINOLOOG still active?

Yes. According to the CBE (1 October 2026) DR. BOER MIRRA, ENDOCRINOLOOG is active, legal situation “Normale toestand”, started on 4 December 2019.

Is DR. BOER MIRRA, ENDOCRINOLOOG registered on Peppol?

Yes, DR. BOER MIRRA, ENDOCRINOLOOG is registered on the Peppol network with ID 0208:0738723492.

What is the enterprise number of DR. BOER MIRRA, ENDOCRINOLOOG?

The enterprise number of DR. BOER MIRRA, ENDOCRINOLOOG is BE0738723492.

When was DR. BOER MIRRA, ENDOCRINOLOOG founded?

DR. BOER MIRRA, ENDOCRINOLOOG was founded on 4 December 2019.

Who are the directors of DR. BOER MIRRA, ENDOCRINOLOOG?

According to the 2025 annual accounts, the directors of DR. BOER MIRRA, ENDOCRINOLOOG are: MIRRA BOER.

Is DR. BOER MIRRA, ENDOCRINOLOOG a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 4 December 2019; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. BOER MIRRA, ENDOCRINOLOOG make in 2025?

DR. BOER MIRRA, ENDOCRINOLOOG posted a profit after taxes of € 113,539 in financial year 2025.

What is the revenue of DR. BOER MIRRA, ENDOCRINOLOOG?

As a small company, DR. BOER MIRRA, ENDOCRINOLOOG is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 144,653.

DR. BOER MIRRA, ENDOCRINOLOOG (Private Limited) - Deinze

Dossier DR. BOER MIRRA, ENDOCRINOLOOG, printed on 1 October 2026 from databakkes.be/en/0738723492/dr-boer-mirra-endocrinoloog. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. BOER MIRRA, ENDOCRINOLOOG from Deinze, company number BE0738723492, closed financial year 2025 with a result of € 113,539 after tax. For that financial year DR. BOER MIRRA, ENDOCRINOLOOG recorded a gross margin of € 144,653 and equity of € 127,772. Compared with financial year 2024, the result moved from € 119,485 to € 113,539. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 20, 2026.

What it is worth Growing

€ 127,772

▲ € 113,539 vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 113,539

▼ 5% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 32,611

▼ 43% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 122,772.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Taxes and wages

€ 6,336

▼ 11% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 177,246 Gross margin 2022: € 177,246 First fiscal year in the series	€ 119,219 Gross margin 2023: € 119,219 ▼ 33% vs 2022 (€ 177,246) Unfavourable step	€ 152,206 Gross margin 2024: € 152,206 ▲ 28% vs 2023 (€ 119,219) Favourable step	€ 144,653 Gross margin 2025: € 144,653 ▼ 5% vs 2024 (€ 152,206) Unfavourable step	▼ 5%
Profit after taxes	€ 136,351 Profit after taxes 2022: € 136,351 First fiscal year in the series	€ 96,111 Profit after taxes 2023: € 96,111 ▼ 30% vs 2022 (€ 136,351) Unfavourable step	€ 119,485 Profit after taxes 2024: € 119,485 ▲ 24% vs 2023 (€ 96,111) Favourable step	€ 113,539 Profit after taxes 2025: € 113,539 ▼ 5% vs 2024 (€ 119,485) Unfavourable step	▼ 5%
Equity	€ 348,636 Equity 2022: € 348,636 First fiscal year in the series	€ 14,747 Equity 2023: € 14,747 ▼ 96% vs 2022 (€ 348,636) Unfavourable step	€ 14,232 Equity 2024: € 14,232 ▼ 3% vs 2023 (€ 14,747) Unfavourable step	€ 127,772 Equity 2025: € 127,772 ▲ € 113,539 vs 2024 (€ 14,232) Favourable step	▲ € 113,539
Total debts	€ 57,875 Total debts 2022: € 57,875 First fiscal year in the series	€ 125,954 Total debts 2023: € 125,954 ▲ 118% vs 2022 (€ 57,875) Unfavourable step	€ 171,348 Total debts 2024: € 171,348 ▲ 36% vs 2023 (€ 125,954) Unfavourable step	€ 12,419 Total debts 2025: € 12,419 ▼ 93% vs 2024 (€ 171,348) Favourable step	▼ 93%
Cash	€ 36,309 Cash 2022: € 36,309 First fiscal year in the series	€ 94,651 Cash 2023: € 94,651 ▲ 161% vs 2022 (€ 36,309) Favourable step	€ 57,420 Cash 2024: € 57,420 ▼ 39% vs 2023 (€ 94,651) Unfavourable step	€ 32,611 Cash 2025: € 32,611 ▼ 43% vs 2024 (€ 57,420) Unfavourable step	▼ 43%
Retained profit	€ 343,636 Retained profit 2022: € 343,636 First fiscal year in the series	€ 9,747 Retained profit 2023: € 9,747 ▼ 97% vs 2022 (€ 343,636) Unfavourable step	€ 9,232 Retained profit 2024: € 9,232 ▼ 5% vs 2023 (€ 9,747) Unfavourable step	€ 122,772 Retained profit 2025: € 122,772 ▲ € 113,539 vs 2024 (€ 9,232) Favourable step	▲ € 113,539
Dividend	€ 800 Dividend 2022: € 800 First fiscal year in the series	€ 430,000 Dividend 2023: € 430,000 ▲ € 429,200 vs 2022 (€ 800) Unchanged	€ 120,000 Dividend 2024: € 120,000 ▼ 72% vs 2023 (€ 430,000) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 120,000) Unchanged	▼ 100%
Balance sheet total	€ 406,512 Balance sheet total 2022: € 406,512 First fiscal year in the series	€ 140,701 Balance sheet total 2023: € 140,701 ▼ 65% vs 2022 (€ 406,512) Unchanged	€ 185,581 Balance sheet total 2024: € 185,581 ▲ 32% vs 2023 (€ 140,701) Unchanged	€ 140,191 Balance sheet total 2025: € 140,191 ▼ 24% vs 2024 (€ 185,581) Unchanged	▼ 24%

Key figures of DR. BOER MIRRA, ENDOCRINOLOOG, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. BOER MIRRA, ENDOCRINOLOOG?

What happened at DR. BOER MIRRA, ENDOCRINOLOOG in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 20, 2026 New annual accounts for financial year 2025: profit of € 113,539 (▼ 5% vs 2024). Source: NBB ↗
Dec 4, 2019 New establishment in Gent. KBO
Dec 4, 2019 Start of the company according to the CBE. KBO

In short

From € 136,351 profit in 2022 to € 113,539 profit in 2025.

Paid € 129,609 in corporate taxes since 2022.

Best year ever: 2022, with € 136,351 profit.

Paid out € 550,800 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. BOER MIRRA, ENDOCRINOLOOG? We notify you, reason included.

Follow DR. BOER MIRRA, ENDOCRINOLOOG

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit